Lv1
40 积分 2024-01-15 加入
Fc Receptors
20天前
已完结
Exploring new perspectives in immunology
21天前
已完结
Breaking through the therapeutic ceiling of inflammatory bowel disease: Dual-targeted therapies
1个月前
已完结
Manufacturing innovation to drive down cell therapy costs
1个月前
已完结
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
1个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
1个月前
已完结
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
2个月前
已完结
Valuation and design of pharmaceutical R&D licensing deals
2个月前
已完结
Bispecific antibody takes a BiTE out of B cells in rheumatoid arthritis
3个月前
已完结
How to pay for individualized genetic medicines
3个月前
已完结
皖公网安备34019202002308
